A repeat administration of OBZ (1 g) was performed 10 months later due to B-cell repopulation, rising proteinuria (0.6 g/24 h), and mild hypoalbuminemia (serum albumin 3.4 g/dL), successfully re-inducing complete remission (proteinuria 0.2 g/24 h, serum albumin 3.8 g/dL).<h4>Discussion</h4>This case illustrates the potential of OBZ as an effective therapeutic option in podocytopathies with RTX inadequate response. Here, ALB is linked to Hypoalbuminemia.